Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTAW) Shares Outstanding (Weighted Average) (2019 - 2025)

Historic Shares Outstanding (Weighted Average) for Strata Critical Medical (SRTAW) over the last 7 years, with Q3 2025 value amounting to $82.5 million.

  • Strata Critical Medical's Shares Outstanding (Weighted Average) rose 565.12% to $82.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.5 million, marking a year-over-year increase of 565.12%. This contributed to the annual value of $77.5 million for FY2024, which is 540.63% up from last year.
  • Strata Critical Medical's Shares Outstanding (Weighted Average) amounted to $82.5 million in Q3 2025, which was up 565.12% from $81.3 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Shares Outstanding (Weighted Average) registered a high of $82.5 million during Q3 2025, and its lowest value of $26.1 million during Q1 2021.
  • Over the past 5 years, Strata Critical Medical's median Shares Outstanding (Weighted Average) value was $73.2 million (recorded in 2023), while the average stood at $69.5 million.
  • As far as peak fluctuations go, Strata Critical Medical's Shares Outstanding (Weighted Average) surged by 62026.93% in 2021, and later skyrocketed by 172.19% in 2023.
  • Strata Critical Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $69.8 million in 2021, then grew by 2.12% to $71.2 million in 2022, then rose by 3.21% to $73.5 million in 2023, then grew by 5.41% to $77.5 million in 2024, then increased by 6.39% to $82.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $82.5 million in Q3 2025, compared to $81.3 million in Q2 2025 and $79.9 million in Q1 2025.